Iparomlimab and Tuvonralimab Plus Chemotherapy as Neoadjuvant Therapy for Ovarian Cancer（Phase II）
Clinical trial NCT07673835 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07673835
- Sponsor
- Obstetrics & Gynecology Hospital of Fudan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-06
- Primary completion
- 2028-12-31
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.